In June 2022 the Anti-Doping Agency of Kenya (ADAK) has reported an anti-doping rule violation against the Athlete Alice Aprot Nawowuma after her sample tested positive for the prohibited substance Letrozole.
Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Kenya Sports Disputes Tribunal.
The Athlete accepted the test result and denied the intentional use of the substance. She explained she had used prescribed medication as treatment for her condition.
The Athlete had a problem with breast milk production and visited a pharmacy near her trainingcamp in Nairobi. She informed the pharmacy that she was an Athlete submitted to Doping Control.
The pharmacy assured that her medication did not contain probibited substances. She did not know what medication she had received, nor had she checked this medication before using.
ADAK contended that het Athlete failed to demonstrate that the violation was not intentional and requested the Panel to impose a sanction of 4 years.
The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.
After assessment of the evidence the Panel deems that the Athlete had not filed relevant evidence that corroborates her testimony. Consequently the Panel concludes that the Athlete failed to establish the source of the prohibited substance, nor that the violation was not intentonal.
Therefore the Sports Disputes Tribunal decides on 2 March 2023 to impose a 4 year period of inelgibility on the Athlete, starting on the date of the provisional suspension, i.e. on 14 July 2022.
